Adaptimmune Therapeutics PLC (ADAP)

Last Closing Price: 0.06 (2025-08-29)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Adaptimmune Therapeutics PLC (ADAP) Expense Ratio data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$13.68M
$-30.34M
$2.50M
$11.18M
$43.97M
$-30.29M
$0.56M
$-29.73M
$-29.73M
$-30.34M
$-30.34M
$-30.34M
$-30.34M
$-30.29M
$-27.78M
264.09M
264.09M
$-0.12
$-0.12
Balance Sheet Financials
$78.11M
$28.15M
$52.52M
$130.63M
$51.51M
$25.68M
$150.08M
$201.59M
$-70.96M
$-74.77M
$-70.96M
265.05M
Cash Flow Statement Financials
$-101.37M
$59.64M
$-23.67M
$93.21M
$27.78M
$-65.43M
$1.99M
--
--
Fundamental Metrics & Ratios
1.52
--
--
-0.57
-0.36
81.71%
-221.45%
-221.45%
--
-217.36%
-221.83%
$-102.65M
--
Expense Ratio
--
--
0.10
0.22
1.47
61.28
42.76%
40.58%
-23.23%
67.00%
$-0.27
$-0.39
$-0.38